StockWatch
·
Pharmaceutical Preparations
AcquisitionsAug 5, 2026, 05:23 PM

Vireo Growth Acquires Four Ohio Cannabis Entities for $208M

AI Summary

Vireo Growth Inc. announced a four-deal transaction to acquire FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, CAOH LLC, and Canoe Hill Ohio, LLC for approximately $208 million. This strategic move, paid entirely in approximately 11 million subordinate voting shares, will establish a vertically integrated cannabis platform in Ohio, including eight dispensaries and a cultivation facility. The acquisition expands Vireo's national presence to 16 states and approximately 270 dispensaries, with closing expected in Q4 2026.

Key Highlights

  • Vireo Growth to acquire four Ohio cannabis entities for approximately $208 million.
  • Acquisition includes eight dispensaries, a cultivation and processing facility, and real estate.
  • Consideration consists of approximately 11 million subordinate voting shares of Vireo.
  • Payment will be made in three tranches: 50% at closing, 25% at 90 days, 25% at 180 days.
  • Expands Vireo's national footprint to 16 states and approximately 270 dispensaries.
  • Includes a performance-based clawback mechanism for up to 25% of shares.
  • CEO John Mazarakis is a seller in one of the transactions (CAOH LLC).
  • Closing of the Ohio Transactions is expected in Q4 2026, subject to regulatory approvals.